204 related articles for article (PubMed ID: 17588937)
21. Cortisol promotes endoplasmic glucose production via pyridine nucleotide redox.
Wang Z; Mick GJ; Xie R; Wang X; Xie X; Li G; McCormick KL
J Endocrinol; 2016 Apr; 229(1):25-36. PubMed ID: 26860459
[TBL] [Abstract][Full Text] [Related]
22. The glucose-6-phosphate transporter-hexose-6-phosphate dehydrogenase-11beta-hydroxysteroid dehydrogenase type 1 system of the adipose tissue.
Marcolongo P; Piccirella S; Senesi S; Wunderlich L; Gerin I; Mandl J; Fulceri R; Bánhegyi G; Benedetti A
Endocrinology; 2007 May; 148(5):2487-95. PubMed ID: 17303657
[TBL] [Abstract][Full Text] [Related]
23. Hexose-6-phosphate dehydrogenase modulates the effect of inhibitors and alternative substrates of 11beta-hydroxysteroid dehydrogenase 1.
Balázs Z; Nashev LG; Chandsawangbhuwana C; Baker ME; Odermatt A
Mol Cell Endocrinol; 2009 Mar; 301(1-2):117-22. PubMed ID: 19010388
[TBL] [Abstract][Full Text] [Related]
24. Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis.
Konopelska S; Kienitz T; Hughes B; Pirlich M; Bauditz J; Lochs H; Strasburger CJ; Stewart PM; Quinkler M
Clin Endocrinol (Oxf); 2009 Apr; 70(4):554-60. PubMed ID: 18665910
[TBL] [Abstract][Full Text] [Related]
25. Interplay between H6PDH and 11β-HSD1 implicated in the pathogenesis of type 2 diabetes mellitus.
Yao F; Chen L; Fan Z; Teng F; Zhao Y; Guan F; Zhang M; Liu Y
Bioorg Med Chem Lett; 2017 Sep; 27(17):4107-4113. PubMed ID: 28751144
[TBL] [Abstract][Full Text] [Related]
26. H6PDH interacts directly with 11beta-HSD1: implications for determining the directionality of glucocorticoid catalysis.
Zhang YL; Zhong X; Gjoka Z; Li Y; Stochaj W; Stahl M; Kriz R; Tobin JF; Erbe D; Suri V
Arch Biochem Biophys; 2009 Mar; 483(1):45-54. PubMed ID: 19121282
[TBL] [Abstract][Full Text] [Related]
27. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
Harno E; Cottrell EC; Keevil BG; DeSchoolmeester J; Bohlooly-Y M; Andersén H; Turnbull AV; Leighton B; White A
Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962
[TBL] [Abstract][Full Text] [Related]
28. The Role and Regulation of the 11 Beta-Hydroxysteroid Dehydrogenase Enzyme System in Patients with Inflammatory Bowel Disease.
Hussey M; Holleran G; Smith S; Sherlock M; McNamara D
Dig Dis Sci; 2017 Dec; 62(12):3385-3390. PubMed ID: 28932959
[TBL] [Abstract][Full Text] [Related]
29. Direct protein-protein interaction of 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the endoplasmic reticulum lumen.
Atanasov AG; Nashev LG; Gelman L; Legeza B; Sack R; Portmann R; Odermatt A
Biochim Biophys Acta; 2008 Aug; 1783(8):1536-43. PubMed ID: 18381077
[TBL] [Abstract][Full Text] [Related]
30. Lack of significant metabolic abnormalities in mice with liver-specific disruption of 11β-hydroxysteroid dehydrogenase type 1.
Lavery GG; Zielinska AE; Gathercole LL; Hughes B; Semjonous N; Guest P; Saqib K; Sherlock M; Reynolds G; Morgan SA; Tomlinson JW; Walker EA; Rabbitt EH; Stewart PM
Endocrinology; 2012 Jul; 153(7):3236-48. PubMed ID: 22555437
[TBL] [Abstract][Full Text] [Related]
31. 11beta-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response.
Tomlinson JW; Walker EA; Bujalska IJ; Draper N; Lavery GG; Cooper MS; Hewison M; Stewart PM
Endocr Rev; 2004 Oct; 25(5):831-66. PubMed ID: 15466942
[TBL] [Abstract][Full Text] [Related]
32. The metabolism of steroids, toxins and drugs by 11β-hydroxysteroid dehydrogenase 1.
Zhou HY; Hu GX; Lian QQ; Morris D; Ge RS
Toxicology; 2012 Feb; 292(1):1-12. PubMed ID: 22154985
[TBL] [Abstract][Full Text] [Related]
33. Modification of microsomal 11beta-HSD1 activity by cytosolic compounds: glutathione and hexose phosphoesters.
McCormick KL; Wang X; Mick GJ
J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):18-23. PubMed ID: 18550363
[TBL] [Abstract][Full Text] [Related]
34. Endogenous inhibitors (GALFs) of 11beta-hydroxysteroid dehydrogenase isoforms 1 and 2: derivatives of adrenally produced corticosterone and cortisol.
Morris DJ; Latif SA; Hardy MP; Brem AS
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):161-8. PubMed ID: 17459698
[TBL] [Abstract][Full Text] [Related]
35. Hepatic reduction of the secondary bile acid 7-oxolithocholic acid is mediated by 11β-hydroxysteroid dehydrogenase 1.
Odermatt A; Da Cunha T; Penno CA; Chandsawangbhuwana C; Reichert C; Wolf A; Dong M; Baker ME
Biochem J; 2011 Jun; 436(3):621-9. PubMed ID: 21453287
[TBL] [Abstract][Full Text] [Related]
36. Activation of the hypothalamic-pituitary-adrenal axis in obesity: cause or consequence?
Walker BR
Growth Horm IGF Res; 2001 Jun; 11 Suppl A():S91-5. PubMed ID: 11527096
[TBL] [Abstract][Full Text] [Related]
37. Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient mice.
Harris HJ; Kotelevtsev Y; Mullins JJ; Seckl JR; Holmes MC
Endocrinology; 2001 Jan; 142(1):114-20. PubMed ID: 11145573
[TBL] [Abstract][Full Text] [Related]
38. Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys.
Wiegand S; Richardt A; Remer T; Wudy SA; Tomlinson JW; Hughes B; Grüters A; Stewart PM; Strasburger CJ; Quinkler M
Eur J Endocrinol; 2007 Sep; 157(3):319-24. PubMed ID: 17766714
[TBL] [Abstract][Full Text] [Related]
39. Hypothalamic-pituitary-adrenal axis abnormalities in response to deletion of 11beta-HSD1 is strain-dependent.
Carter RN; Paterson JM; Tworowska U; Stenvers DJ; Mullins JJ; Seckl JR; Holmes MC
J Neuroendocrinol; 2009 Nov; 21(11):879-87. PubMed ID: 19602102
[TBL] [Abstract][Full Text] [Related]
40. Genistein inhibits glucocorticoid amplification in adipose tissue by suppression of 11β-hydroxysteroid dehydrogenase type 1.
Tagawa N; Kubota S; Kobayashi Y; Kato I
Steroids; 2015 Jan; 93():77-86. PubMed ID: 25447798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
